The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension

References

• AessoposAFarmakisDKaragiorgaMCardiac involvement in thalassemia intermedia: a multicenter studyBlood200197113411341611369631
   PubMed Web of Science ®Google Scholar
• BadeschDBChampionHCSanchezMADiagnosis and assessment of pulmonary arterial hypertensionJ Am Coll Cardiol2009541 SupplS55S6619555859
   PubMed Web of Science ®Google Scholar
• ChueamuangphanNWongtheptienWNawarawongWSukornthasarnAChuncharuneeSTawichasriCPatumanondJClinical indicators for pulmonary arterial hypertension in thalassemiaJ Med Assoc Thai20129511622379736
   PubMedGoogle Scholar
• UssavarungsiKBurgerCDPulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literaturePulm Circ20144352052625621166
   PubMed Web of Science ®Google Scholar
• TaherATMusallamKMKarimiMOverview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE studyBlood2010115101886189220032507
   PubMed Web of Science ®Google Scholar
• KalantariSGomberg-MaitlandMGroup 5 pulmonary hypertension: the orphan’s orphan diseaseCardiol Clin201634344344927443140
   PubMed Web of Science ®Google Scholar
• DerchiGGalanelloRBinaPWebthal Pulmonary Arterial Hypertension Group*Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal studyCirculation2014129333834524081970
   PubMed Web of Science ®Google Scholar
• AessoposAFarmakisDPulmonary hypertension in beta-thalassemiaAnn N Y Acad Sci20051054134234916339682
   PubMed Web of Science ®Google Scholar
• AtichartakarnVChuncharuneeSChandanamatthaPLikittanasombatKAryurachaiKCorrection of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patientBlood200410372844284614645000
   PubMed Web of Science ®Google Scholar
• BarstRJMubarakKKMachadoRFASSET study group*Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesBr J Haematol2010149342643520175775
   PubMed Web of Science ®Google Scholar
• RybickiACBenjaminLJIncreased levels of endothelin-1 in plasma of sickle cell anemia patientsBlood1998927259425969746804
   PubMed Web of Science ®Google Scholar
• SingerSTKuypersFFinemanJElevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomyAnn Hematol20149371139114824577514
   PubMed Web of Science ®Google Scholar
• MinnitiCPMachadoRFColesWASachdevVGladwinMTKatoGJEndothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell diseaseBr J Haematol2009147573774319775299
   PubMed Web of Science ®Google Scholar
• ProvencherSGrantonJTCurrent treatment approaches to pulmonary arterial hypertensionCan J Cardiol201531446047725840096
   PubMed Web of Science ®Google Scholar
• SurieSReesinkHJMarcusJTBosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertensionClin Cardiol2013361169870324037998
   PubMed Web of Science ®Google Scholar
• DerchiGForniGLFormisanoFEfficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathiesHaematologica200590445245815820939
   PubMed Web of Science ®Google Scholar
• AnthiATsangarisIHamodrakaESLekakisJArmaganidisAOrfanosSETreatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertensionBlood201212071531153222899478
   PubMed Web of Science ®Google Scholar
• FarmakisDAessoposAPulmonary hypertension associated with hemoglobinopathies: prevalent but overlookedCirculation2011123111227123221422398
   PubMed Web of Science ®Google Scholar
• KosaryanMRahimiMDarvishi-KhezriHGholizadehNAkbarzadehRAliasgharianACorrelation of pancreatic iron overload measured by T2*-weighted magnetic resonance imaging in diabetic patients with β-thalassemia majorHemoglobin201741315115628762844
   PubMed Web of Science ®Google Scholar
• GodaraHThe Washington Manual of Medical TherapeuticsPhiladelphia (PA)Lippincott Williams & Wilkins20136263
   Google Scholar
• ZipesDPLibbyPBonowROMannDLTomaselliGFBraunwald’s Heart Disease E-Book: A Textbook of Cardiovascular MedicinePhiladelphiaElsevier Health Sciences2018152
   Google Scholar
• McLaughlinVVSitbonOBadeschDBSurvival with first-line bosentan in patients with primary pulmonary hypertensionEur Respir J200525224424915684287
   PubMed Web of Science ®Google Scholar
• AnthiAMachadoRFJisonMLHemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertensionAm J Respir Crit Care Med2007175121272127917379852
   PubMed Web of Science ®Google Scholar
• CappelliniMDRobbioloLBottassoBMCoppolaRFiorelliGMannucciAPVenous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermediaBr J Haematol2000111246747311122086
   PubMed Web of Science ®Google Scholar
• SingerSTKuypersFAStylesLVichinskyEPFooteDRosenfeldHPulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable stateAm J Hematol200681967067516795058
   PubMed Web of Science ®Google Scholar
• FactorJMPottipatiSRRappoportIRosnerIKLesserMLGiardinaPJPulmonary function abnormalities in thalassemia major and the role of iron overloadAm J Respir Crit Care Med19941496157015748004315
   PubMed Web of Science ®Google Scholar
• FayedMAAbdel-HadyHEHafezMMSalamaOSAl-TonbaryYAStudy of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with β-thalassemiaHematol Oncol Stem Cell Ther2018112657428633041
   PubMedGoogle Scholar
• KarimiMMusallamKMCappelliniMDRisk factors for pulmonary hypertension in patients with β thalassemia intermediaEur J Intern Med201122660761022075289
   PubMed Web of Science ®Google Scholar
• CamaschellaCCappelliniMDThalassemia intermediaHaematologica199580158687758995
   PubMed Web of Science ®Google Scholar
• MusumeciSLeonardiSDi DioRFischerADi CostaGProtein C and antithrombin III in polytransfused thalassemic patientsActa Haematol198777130333107318
   PubMed Web of Science ®Google Scholar
• EldorADurstRHy-AmEA chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhoodBr J Haematol1999107473974610606878
   PubMed Web of Science ®Google Scholar
• OlfertIMLoeckingerATremlBSildenafil and bosentan improve arterial oxygenation during acute hypoxic exercise: a controlled laboratory trialWilderness Environ Med201122321122121723164
   PubMed Web of Science ®Google Scholar
• HayesMMVedamurthyAGeorgeGAmerican Thoracic Society Implementation Task ForcePulmonary hypertension in sickle cell diseaseAnn Am Thorac Soc20141191488148925423000
   PubMedGoogle Scholar
• StewartGWAmessJAEberSWKingswoodCLanePASmithBDMentzerWCThrombo-embolic disease after splenectomy for hereditary stomatocytosisBr J Haematol19969323033108639421
   PubMed Web of Science ®Google Scholar